LARGE1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Viral delivery of LARGE to skeletal muscle in animal models of dystroglycanopathy has identical effects in vivo, suggesting that the restoration of functional glycosylation could have therapeutic applications in these disorders.